Table 1.

Baseline characteristics.

Patient	Age/Sex	Peripheral blood WBCs/blasts (%)	BM blasts (%)	Cytogenetics at diagnosis
1	70/F	1.8/1	33	High risk
2	64/M	2.4/6	78	Intermediate risk
3	82/M	43.3/38	92	Intermediate risk
4	76/M	3.0/47	31	High risk
5	72/F	1.5/13	49	Intermediate risk
6	74/M	2.5/0	44	High risk
7	82/F	3.1/3	65	High risk
8	77/M	3.2/12	37	Intermediate risk
9	71/F	36.5/7	40	High risk
10	80/F	3.3/4	61	Intermediate risk
11	69/M	1.2/8	81	Intermediate risk
12	77/M	12.6/11	73	Intermediate risk
13	71/M	2.3/0	29	Not available
14	80/F	2.9/7	43	Intermediate risk
15	69/M	1.2/10	33	Intermediate risk

High-risk cytogenetics defined as −5, −7, del (5q), abnormal 3q, or complex karyotype with ≥3 cytogenetic abnormalities; intermediate-risk cytogenetics defined as normal and all other karyotypes except t(8;21), t(15;17), and inv(16). BM, bone marrow; F, female; M, male; WBC, white blood cell.